Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Akorn (AKRX)

Add to Watchlists
Create an Alert
24.06 -0.59  -2.39% NASDAQ Apr 23, 3:59PM BATS Real time Currency in USD
View Full Chart
AKRX Price Chart
View All Events

AKRX Events

Date Type Description
Nov 05 Misc Akorn, Inc. Announces Third Quarter 2013 Earnings Release and Conference Call Information
Nov 05 Earnings THIRD QUARTER 2013 EARNINGS RELEASE. Estimate: 0.13.
Aug 27 Misc Akorn to Acquire Hi-tech Pharmacal for $640 Million
Aug 06 Misc Akorn, Inc. Announces Second Quarter 2013 Earnings Release and Conference Call Information
Aug 06 Earnings AKORN, INC. ANNOUNCES SECOND QUARTER 2013. Estimate: 0.11.
May 07 Misc Akorn Inc. Announces First Quarter 2013 Earnings Release Conference Call Information
May 07 Earnings AKORN, INC. ANNOUNCES FIRST QUARTER 2013 EARNINGS RELEASE. Estimate: 0.11.
May 03 Misc AGM Event for Akorn Inc.
View All Performance Charts

AKRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Akorn is up 63.12% over the last year vs S&P 500 Total Return up 22.59%, Hi-Tech Pharmacal up 30.09%, and Actavis up 107.9%.

Get Quote for

PDF Report for AKRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download AKRX Pro Report PDF
Advertisement

Portfolio Strategies Featuring AKRX

Did Akorn make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

AKRX Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: Illinois
  • Incorporation Country: United States
  • Incorporation State/Province: Louisiana
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Akorn, Inc. is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe. Its customers include physicians, optometrists, hospitals, surgery centers, clinics, long-term care, wholesalers, group purchasing organizations, retail pharmacies and other pharmaceutical companies. The company operates through three reportable segments: Ophthalmic, Hospital Drugs and Injectables and Contract Services. Akorn was founded in 1971 and is headquartered in Lake Forest, Illinois.

Recent Quotes

Symbol Price Chg Chg % Market Cap
AKRX 24.06 -0.59 -2.39% 2.323B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.